[1]
S. Singh, D. K. Makwana, T. Buckley, A. Agrawal, S. V. Koduru, and A. K. Tiwari, “Clinical significance of PARP-1 inhibitors in cancer chemotherapy”, TCB, vol. 1, no. 1, pp. pp.10–14, Oct. 2013, doi: 10.14259/tcb.v1i1.63.